Showing results (71-80 of 169) with videos related to
Sort By:
Pageof 17
Clinical Pharmacology and Therapeutics|July 1, 1980
Pyridostigmine kinetics with and without renal functionR Cronnelly, D R Stanski, R D Miller, et al.Annals of Internal Medicine|May 1, 1975
Improved computer-assisted digoxin therapy. A method using feedback of measured serum digoxin concentrationsL B Sheiner, H Halkin, C Peck, et al.Clinical Pharmacology and Therapeutics|March 1, 1995
A population model for the leukopenic effect of etoposideM O Karlsson, R E Port, M J Ratain, et al.Cardiovascular Research|February 1, 1982
Clearance of serum creatine kinase activityC J Carlson, W Meister, B Emilson, et al.The Journal of Clinical Investigation|November 1, 1987
Apparent tolerance to the acute effect of nicotine results in part from distribution kineticsH C Porchet, N L Benowitz, L B Sheiner, et al.European Journal of Ophthalmology|October 11, 2001
Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucomaL A Wheeler, E WoldemussieEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 7, 2001
Making the most of sparse clinical data by using a predictive-model-based analysis, illustrated with a stavudine pharmacokinetic studyL Zhang, R Price, F Aweeka, et al.Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1984
Extended least squares nonlinear regression: a possible solution to the "choice of weights" problem in analysis of individual pharmacokinetic dataC C Peck, S L Beal, L B Sheiner, et al.Clinical Pharmacology and Therapeutics|March 1, 1979
Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarineL B Sheiner, D R Stanski, S Vozeh, et al.Clinical Chemistry|January 1, 1979
Spironolactone-associated digoxin radioimmunoassay interferenceB Silber, L B Sheiner, J L Powers, et al.Pageof 17